PraNa Biosciences

Pra Na Biosciences

Pharmaceuticals, 371 Tpke Rd, Worcester, Massachusetts, 01772, United States, 1-10 Employees

pranabiosciences.com

  • LinkedIn

Who is PRANA BIOSCIENCES

PraNa Biosciences, Inc. is a specialty pharmaceutical company headquartered in Massachusetts focused on developing and commercializing value enhanced pharmaceutical products. Our strategy...

Read More

map
  • 371 Tpke Rd, Worcester, Massachusetts, 01772, United States Headquarters: 371 Tpke Rd, Worcester, Massachusetts, 01772, United States
  • 2015 Date Founded: 2015
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: Under $1 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Pharmaceuticals

SIC SIC Code: 2834

checked-icon Does something look wrong? Fix it. | View contact records from PRANA BIOSCIENCES

PraNa Biosciences Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding PraNa Biosciences

Answer: PraNa Biosciences's headquarters are located at 371 Tpke Rd, Worcester, Massachusetts, 01772, United States

Answer: PraNa Biosciences's official website is https://pranabiosciences.com

Answer: PraNa Biosciences's revenue is Under $1 Million

Answer: PraNa Biosciences's SIC: 2834

Answer: PraNa Biosciences has 1-10 employees

Answer: PraNa Biosciences is in Pharmaceuticals

Answer: PraNa Biosciences contact info: Phone number: Website: https://pranabiosciences.com

Answer: PraNa Biosciences, Inc. is a specialty pharmaceutical company headquartered in Massachusetts focused on developing and commercializing value enhanced pharmaceutical products. Our strategy involves application of innovative formulations and novel technologies to solve challenges associated with complex marketed products. PraNa has already demonstrated the validity of our approach and formulated our lead compound that is indicated for musculoskeletal pain management. This lead candidate is the subject of a pending patent application and has received favorable pre-IND responses from the FDA for the intended CMC/Clinical development plans that will lead to a 505(b)(2) NDA and commercial product in an expedited timeline.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access